Orthopediatrics (KIDS) Total Debt Growth (3y) (2019 - 2026)
Orthopediatrics (KIDS) Total Debt Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 0.11% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -0.32% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 2.61% |
| 10 | Orthopediatrics | 462.69 Mn | 448.44 Mn | 43.39 Mn | 81.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.87% |
| Dec 31, 2025 | 358.82% |
| Sep 30, 2025 | 374.60% |
| Jun 30, 2025 | -65.06% |
| Mar 31, 2025 | 326.19% |
| Dec 31, 2024 | 304.87% |
| Sep 30, 2024 | 307.86% |
| Jun 30, 2024 | 117.13% |
| Mar 31, 2024 | 115.51% |
| Dec 31, 2023 | -49.43% |
| Sep 30, 2023 | -12.81% |
| Jun 30, 2023 | -65.93% |
| Mar 31, 2023 | -65.48% |
| Dec 31, 2022 | -65.82% |
| Sep 30, 2022 | -73.58% |
| Jun 30, 2022 | -14.47% |
| Mar 31, 2022 | -63.77% |
| Dec 31, 2021 | -61.85% |
| Sep 30, 2021 | -65.12% |
| Jun 30, 2021 | -64.77% |